These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 29358632)
1. CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Singh SK; Mishra MK; Eltoum IA; Bae S; Lillard JW; Singh R Sci Rep; 2018 Jan; 8(1):1323. PubMed ID: 29358632 [TBL] [Abstract][Full Text] [Related]
2. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment. Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571 [TBL] [Abstract][Full Text] [Related]
3. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma. Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063 [TBL] [Abstract][Full Text] [Related]
4. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment. Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803 [TBL] [Abstract][Full Text] [Related]
5. The CCL5/CCR5 Chemotactic Pathway Promotes Perineural Invasion in Salivary Adenoid Cystic Carcinoma. Gao T; Shen Z; Ma C; Li Y; Kang X; Sun M J Oral Maxillofac Surg; 2018 Aug; 76(8):1708-1718. PubMed ID: 29549020 [TBL] [Abstract][Full Text] [Related]
6. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia. Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870 [TBL] [Abstract][Full Text] [Related]
7. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching. Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461 [TBL] [Abstract][Full Text] [Related]
8. CCL5/CCR5 axis promotes the motility of human oral cancer cells. Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035 [TBL] [Abstract][Full Text] [Related]
9. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139 [TBL] [Abstract][Full Text] [Related]
10. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus. Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151 [TBL] [Abstract][Full Text] [Related]
11. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Vaday GG; Peehl DM; Kadam PA; Lawrence DM Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154 [TBL] [Abstract][Full Text] [Related]
12. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer. Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423 [TBL] [Abstract][Full Text] [Related]
13. CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells. Gao D; Rahbar R; Fish EN Open Biol; 2016 Jun; 6(6):. PubMed ID: 27335323 [TBL] [Abstract][Full Text] [Related]
14. CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. Wang SW; Wu HH; Liu SC; Wang PC; Ou WC; Chou WY; Shen YS; Tang CH PLoS One; 2012; 7(4):e35101. PubMed ID: 22506069 [TBL] [Abstract][Full Text] [Related]
15. CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer. Pervaiz A; Zepp M; Mahmood S; Ali DM; Berger MR; Adwan H Cell Oncol (Dordr); 2019 Feb; 42(1):93-106. PubMed ID: 30456574 [TBL] [Abstract][Full Text] [Related]
16. CR5/CCL5 axis is linked to a poor outcome, and inhibition reduces metastasis in oral squamous cell carcinoma. González-Arriagada WA; Coletta RD; Lozano-Burgos C; García C; Maripillán J; Alcayaga-Miranda F; Godínez-Pacheco B; Oyarce-Pezoa S; Martínez-Flores R; García IE J Cancer Res Clin Oncol; 2023 Dec; 149(19):17335-17346. PubMed ID: 37831273 [TBL] [Abstract][Full Text] [Related]
17. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016 [TBL] [Abstract][Full Text] [Related]
18. Marsdenia tenacissima extract suppresses A549 cell migration through regulation of CCR5-CCL5 axis, Rho C, and phosphorylated FAK. Lin SS; Li FF; Sun L; Fan W; Gu M; Zhang LY; Qin S; Yuan ST Chin J Nat Med; 2016 Mar; 14(3):203-9. PubMed ID: 27025367 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. Aldinucci D; Casagrande N Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686 [TBL] [Abstract][Full Text] [Related]
20. The potential to target CCL5/CCR5 in breast cancer. Velasco-Velázquez M; Xolalpa W; Pestell RG Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]